drugset / Trial / NCT00647699
Corneal Collagen Cross-linking for Progressive Keratoconus
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective, randomized multicenter study to determine the safety and effectiveness of performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with progressive keratoconus.
Timeline
- Start
- 2007-12
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | 0.1 % | Other |
| Comparator | Riboflavin | Other / unclassified | 1.6 ml | Other |